QuidelOrtho (QDEL) Income from Continuing Operations (2021 - 2024)
QuidelOrtho (QDEL) posted Income from Continuing Operations of 1706000000.0 for Q1 2024, down 222.8% sequentially from 528500000.0 in Q4 2023, and down 3595.9% YoY from 48800000.0 in Q2 2023.
QuidelOrtho (QDEL) Income from Continuing Operations (2021 - 2024) Analysis & Trends
QuidelOrtho has reported Income from Continuing Operations for 4 years, with the latest figure at 1706000000.0 in Q1 2024.
- Quarterly Income from Continuing Operations fell 3595.9% year-over-year to 1706000000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 2300400000.0 (down 1131.11% YoY) and the FY2024 annual result came in at 2052000000.0, down 20216.83% from the prior year.
- Income from Continuing Operations declined to 1706000000.0 in Q1 2024 per QDEL's latest filing, from 528500000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 479900000.0 in Q2 2022 and troughed at 1706000000.0 in Q1 2024.
- A 4-year average of 123872727.27 and a median of 19200000.0 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations advanced 1.05% in 2022, then slumped 3595.9% in 2024.
- Over 4 years, Income from Continuing Operations stood at 215700000.0 in 2021, then sank by 91.1% to 19200000.0 in 2022, then slumped by 2852.6% to 528500000.0 in 2023, then plunged by 222.8% to 1706000000.0 in 2024.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 1706000000.0, 528500000.0, and 12700000.0 for Q1 2024, Q4 2023, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | QuidelOrtho | 1.01 Bn | 885.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -1.71 Bn |
| Dec 31, 2023 | -528.50 Mn |
| Oct 1, 2023 | -12.70 Mn |
| Jul 2, 2023 | -53.20 Mn |
| Apr 2, 2023 | 48.80 Mn |
| Jan 1, 2023 | 135.80 Mn |
| Oct 2, 2022 | 19.20 Mn |
| Jul 3, 2022 | 19.30 Mn |
| Apr 3, 2022 | 479.90 Mn |
| Oct 3, 2021 | 215.70 Mn |
| Jul 4, 2021 | 19.10 Mn |